Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination chemotherapy regimen with peripheral stem cell transplantation for stage III ovarian cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrioid Ovarian Carcinoma
• Mucinous Ovarian Carcinoma
• Ovarian Cancer
• Ovarian Clear Cell Carcinoma
• Ovarian Mixed Epithelial Tumor
• Peritoneal Carcinoma
• Serous Ovarian Carcinoma
• Undifferentiated Ovarian Carcinoma

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma | Phase 2 | Status: TERMINATED